Luebke T, Brunkwall J
Department of Vascular and Endovascular Surgery, University of Cologne, Cologne, Germany.
J Cardiovasc Surg (Torino). 2010 Oct;51(5):613-32.
Acute complicated type B aortic dissection is a life-threatening condition. We summarized all published studies for TEVAR among patients with acute complicated typ B aortic dissection (TBAD) with respect to clinical success, complications, and outcomes. Furthermore, we determined whether TEVAR reduces death and morbidity compared with open repair for TBAD.
Studies were identified from a literature search using various databases, and included studies when three or more patients were reported and at least in-hospital mortality was reported. Data from comparative studies of TEVAR versus open repair of the descending aorta in TBAD were combined through meta-analysis.
Seventy-six observational studies involving 1951 patients were included in the present meta-analysis. In-hospital mortality was 11.5% and other major complications (i.e., stroke (6.3%), paraplegia (4.9%), retrograde type A aortic dissection (7%), renal impairment including dialysis (6.9%), bowel infarction (4.1%), vascular problems including major amputation (2.5%)) occurred less frequently. Long-term follow-up was limited to a mean of 24 months. During this time, endovascular reintervention was required in 11.3%, surgical reintervention in 7.7%, and late aortic rupture was calculated for 3.2% of cases. A complete false lumen thrombosis was estimated to occur in 76.1% of cases. In comparative studies, 30-day/in-hospital mortality (OR=0.256, P=0.001) and paraplegia/paraparesis (OR=0.256, P=0.001) were significantly reduced for TEVAR versus open repair. In addition to that, the rate of vascular complications was reduced for TEVAR (OR=0.373, P=0.036). There was no significant difference between TEVAR and open repair in patients with acute complicated TBAD for the following outcomes: late mortality, reintervention rate, renal dysfunction (including dialysis), and stroke rate.
This summary analysis suggests that endovascular treatment of complicated acute type B aortic dissection produces favourable initial outcomes and would seem to be a great addition to the treatment options for this condition. Further study of long-term outcomes is required.
急性复杂性B型主动脉夹层是一种危及生命的疾病。我们总结了所有已发表的关于急性复杂性B型主动脉夹层(TBAD)患者行胸主动脉腔内修复术(TEVAR)的研究,内容涉及临床成功率、并发症及预后。此外,我们还确定了与TBAD开放修复术相比,TEVAR是否能降低死亡率和发病率。
通过检索多个数据库识别相关研究,纳入报告了3例或更多患者且至少报告了院内死亡率的研究。通过荟萃分析合并TBAD中TEVAR与降主动脉开放修复术对比研究的数据。
本荟萃分析纳入了76项观察性研究,共1951例患者。院内死亡率为11.5%,其他主要并发症(即中风(6.3%)、截瘫(4.9%)、逆行性A型主动脉夹层(7%)、包括透析在内的肾功能损害(6.9%)、肠梗死(4.1%)、包括大截肢在内的血管问题(2.5%))发生率较低。长期随访平均限于24个月。在此期间,11.3%的患者需要进行血管腔内再次干预,7.7%的患者需要进行外科再次干预,3.2%的病例发生晚期主动脉破裂。估计76.1%的病例出现完全性假腔血栓形成。在对比研究中,与开放修复术相比,TEVAR组30天/院内死亡率(OR = 0.256,P = 0.001)和截瘫/轻瘫(OR = 0.256,P = 0.001)显著降低。除此之外,TEVAR组血管并发症发生率降低(OR = 0.373,P = 0.036)。在急性复杂性TBAD患者中,TEVAR与开放修复术在以下预后方面无显著差异:晚期死亡率、再次干预率、肾功能不全(包括透析)及中风发生率。
本汇总分析表明,对复杂性急性B型主动脉夹层进行血管腔内治疗可产生良好的初始预后,似乎是该病治疗选择的一大补充。需要对长期预后进行进一步研究。